Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06061094 |
|---|---|
| Brief Title: | Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT (GMALL-EVOLVE) |
| First Submitted : | August 20, 2023 |
| First Submitted that Met QC Criteria : | September 24, 2023 |
| First Posted : | September 29, 2023 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 6, 2024 |